Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

Summary

This study is a placebo-controlled, randomized, double-blind, multicenter, parallel-group comparison study in primary biliary cholangitis participants inadequately responding to ursodeoxycholic acid.

Timeline

Start

2017-05-29

Primary completion

2018-08-27

Completion

2018-10-22

Outcome

Outcome not reported

Stopped: “Sponsor's decision (non-safety related)”

Drugs

Indications